缺血性卒中静脉溶栓预后预测的研究进展

被引：11

作者：

张心邈

王春娟

廖晓凌

王伊龙

刘丽萍

王春雪

赵性泉

王拥军

机构：

[1] 首都医科大学附属北京天坛医院神经内科

来源：

中国卒中杂志 | 2014年 / 12期

关键词：

缺血性卒中; 静脉溶栓; 预后; 预测模型;

D O I：

暂无

中图分类号：

R743.3 [急性脑血管疾病（中风）];

学科分类号：

摘要：

静脉溶栓是急性缺血性卒中最有效的治疗方法,但同时伴随着出血转化及预后不良风险的增加。本文对急性缺血性卒中静脉溶栓预后不良的危险因素及相关预测模型进行综述,对不同预后预测模型的特点及预测能力进行分析比较,以期帮助临床神经科医师在接诊急性缺血性卒中患者时对于是否行静脉溶栓进行快速评判并指导决策。

引用

页码：1041 / 1047

页数：7

共 29 条

[1] 静脉溶栓后出血转化的风险预测的研究进展附视频
黄镪
武剑
[J]. 中国卒中杂志, 2013, (03) : 190 - 194+196+195
[2] Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome: An Analysis of the Third International Stroke Trial[J] . William N. Whiteley,Douglas Thompson,Gordon Murray,Geoff Cohen,Richard I. Lindley,Joanna Wardlaw,Peter Sandercock.Stroke . 2014 (4)
[3] THRIVE Score Predicts Ischemic Stroke Outcomes and Thrombolytic Hemorrhage Risk in VISTA
Flint, Alexander C.
Faigeles, Bonnie S.
Cullen, Sean P.
Kamel, Hooman
Rao, Vivek A.
Gupta, Rishi
Smith, Wade S.
Bath, Philip M.
Donnan, Geoffrey A.
[J]. STROKE, 2013, 44 (12) : 3365 - 3369
[4] Validation of the DRAGON Score in 12 Stroke Centers in Anterior and Posterior Circulation
Strbian, Daniel
Seiffge, David J.
Breuer, Lorenz
Numminen, Heikki
Michel, Patrik
Meretoja, Atte
Coote, Skye
Bordet, Regis
Obach, Victor
Weder, Bruno
Jung, Simon
Caso, Valeria
Curtze, Sami
Ollikainen, Jyrki
Lyrer, Philippe A.
Eskandari, Ashraf
Mattle, Heinrich P.
Chamorro, Angel
Leys, Didier
Bladin, Christopher
Davis, Stephen M.
Koehrmann, Martin
Engelter, Stefan T.
Tatlisumak, Turgut
[J]. STROKE, 2013, 44 (10) : 2718 - 2721
[5] Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100[J] . Gustavo Saposnik,Amy K. Guzik,Mathew Reeves,Bruce Ovbiagele,S. Claiborne Johnston.Neurology . 2013 (1)
[6] Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-Analysis of 55 Studies[J] . William N. Whiteley,Karsten Bruins Slot,Peter Fernandes,Peter Sandercock,Joanna Wardlaw.Stroke . 2012 (11)
[7] Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator
Menon, Bijoy K.
Saver, Jeffrey L.
Prabhakaran, Shyam
Reeves, Mathew
Liang, Li
Olson, DaiWai M.
Peterson, Eric D.
Hernandez, Adrian F.
Fonarow, Gregg C.
Schwamm, Lee H.
Smith, Eric E.
[J]. STROKE, 2012, 43 (09) : 2293 - +
[8] The iScore Predicts Efficacy and Risk of Bleeding in the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Stroke Trial[J] . Gustavo Saposnik,Andrew Demchuk,Jack V. Tu,S. Claiborne Johnston.Journal of Stroke and Cerebrovascular Diseases . 2012
[9] Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase: Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score[J] . Michael Mazya,José A. Egido,Gary A. Ford,Kennedy R. Lees,Robert Mikulik,Danilo Toni,Nils Wahlgren,Niaz Ahmed.Stroke . 2012 (6)
[10] Improved Prediction of Poor Outcome After Thrombolysis Using Conservative Definitions of Symptomatic Hemorrhage
Gumbinger, Christoph
Gruschka, Philipp
Boettinger, Markus
Heerlein, Kristin
Barrows, Robin
Hacke, Werner
Ringleb, Peter
[J]. STROKE, 2012, 43 (01) : 240 - 242

← 1 2 3 →